| 前收盘价格 | 2.65 |
| 收盘价格 | 2.68 |
| 成交量 | 7,536,000 |
| 平均成交量 (3个月) | 5,400,375 |
| 市值 | 4,533,116,928 |
| 价格/销量 (P/S) | 20.61 |
| 股市价格/股市净资产 (P/B) | 4.75 |
| 52周波幅 |
| 营业毛利率 | -35.41% |
| 营业利益率 (TTM) | -137.98% |
| 稀释每股收益 (EPS TTM) | -0.040 |
| 季度收入增长率 (YOY) | -13.20% |
| 总债务/股东权益 (D/E MRQ) | 85.91% |
| 流动比率 (MRQ) | 0.750 |
| 营业现金流 (OCF TTM) | -290.37 M |
| 杠杆自由现金流 (LFCF TTM) | -150.46 M |
| 资产报酬率 (ROA TTM) | -11.33% |
| 股东权益报酬率 (ROE TTM) | -10.26% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (HK) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | LEPU BIO-B | - | - |
AIStockmoo 评分
-0.6
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | 2.0 |
| 平均 | -0.63 |
相关股票
| 股票 | 市值 | DY | P/E（TTM） | P/B |
|---|---|---|---|---|
| LEPU BIO-B | 5 B | - | - | 4.75 |
| FRONTAGE | 3 B | - | 83.00 | 1.29 |
| ALPHAMAB-B | 3 B | - | - | 1.88 |
| ABBISKO-B | 3 B | - | - | 1.21 |
| CSTONE PHARMA-B | 3 B | - | - | 5.94 |
| GENOR-B | 930 M | - | - | 0.800 |
|
Lepu Biopharma Co Ltd is a biopharmaceutical company focusing on oncology therapeutics and has one operating segment. The Group is principally engaged in the sales of pharmaceutical products and the research and development of new drugs. The majority operating entity of the Group is domiciled in the PRC. The company has established an integrated end-to-end platform across drug discovery, clinical development, CMC, and GMP-compliant manufacturing, encompassing all critical functions of the biopharmaceutical value chain. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 62.93% |
| 机构持股比例 | 5.44% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合